Companies to collaborate on an exclusive basis on Alizé Pharma's unacylated ghrelin (AZP-01) program for the treatment of Type II diabetes

The FINOVI Foundation is launching a call for a young research team leader in the field of viral hepatitis in Lyon/Grenoble (France).

IMAXIO announces the installation of the new Illumina Ultra High Throughput genotyping platform in its enlarged Clermont-Ferrand facilities